RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.280
+0.040 (1.79%)
Apr 24, 2025, 10:40 AM EDT - Market open

RedHill Biopharma Market Cap

RedHill Biopharma has a market cap or net worth of $3.99 million as of April 24, 2025. Its market cap has decreased by -76.08% in one year.

Market Cap
3.99M
Enterprise Value
-336.50K
1-Year Change
-76.08%
Ranking
Category
Stock Price
$2.28

Market Cap Chart

Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $3.99M, a decrease of -93.21%. That is a compound annual growth rate of -19.64%.

History

DateMarket Cap% Change
Apr 23, 20252.90M-63.29%
Dec 31, 20247.90M68.09%
Dec 29, 20234.70M-47.78%
Dec 30, 20229.00M-92.54%
Dec 31, 2021120.70M-57.65%
Dec 31, 2020285.00M65.51%
Dec 31, 2019172.20M45.81%
Dec 31, 2018118.10M34.66%
Dec 29, 201787.70M-34.06%
Dec 30, 2016133.00M17.49%
Dec 31, 2015113.20M31.93%
Dec 31, 201485.80M37.28%
Dec 31, 201362.50M6.29%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.45B
UnitedHealth Group 386.04B
Johnson & Johnson 377.62B
AbbVie 305.91B
Novo Nordisk 266.18B
Abbott Laboratories 226.81B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings